Radioprotective effect of a metalloporphyrin compound in rat eye model

Current Eye Research

Volumn 34, Issue 1, 2009, Pages 62-72

  Mao, X W ^a,c   Crapo, J D ^b   Mekonnen, T ^a   Lindsey, N ^a   Martinez, P ^a   Gridley, D S ^a   Slater, J M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Microvessel; Photoreceptor; Proton radiation; Retina

Indexed keywords

MANGANESE MESO TETRAKIS(N ETHYLPYRIDINIUM 2 YL)PORPHYRIN; METALLOPORPHYRIN; UNCLASSIFIED DRUG; ANTIOXIDANT; CASPASE 3; MANGANESE (III) MESO TETRAKIS(N ETHYLPYRIDINIUM 2 YL)PORPHYRIN; MANGANESE (III) MESO-TETRAKIS(N-ETHYLPYRIDINIUM-2-YL)PORPHYRIN; PROTON; RADIOPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EYE INJURY; EYE PROTECTION; HISTOLOGY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; RETINA BLOOD VESSEL; RETINA CAPILLARY; ANIMAL; CATARACT; CLASSIFICATION; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; LENS; METABOLISM; PATHOLOGY; RETINA; RETINA DISEASE; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CATARACT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LENS, CRYSTALLINE; MALE; METALLOPORPHYRINS; PHOTORECEPTOR CELLS, VERTEBRATE; PROTONS; RADIATION DOSAGE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL DISEASES; RETINAL VESSELS; TREATMENT OUTCOME;

EID: 59449107338     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802546948     Document Type: Article

References (41)

1. von Sonntag C. The Chemical Basis of Radiation Biology. London: Taylor and Francis, 1987.
2. Fajardo LF. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 2005;44:13-22.
3. Shichi H. Cataract formation and prevention. Expert Opin Invest Drugs 2004;13:691-701.
4. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
5. Lu M, Kuroki M, Amano S. Advance glycation end-products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998;101:1219-1224.
6. van Reyk DM, Gillies MC, Davies MJ. The retina: Oxidative stress and diabetes. Redox Rep. 2003;8:187-192.
7. Ohia SE, Opere CA, LeDay AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res. 2005;579:22-36.
8. Archambeau JO, Mao XW, McMillan PJ, Gouloumet VL, Oeinck SC, Grove R, Yonemoto LT, Slater JD, Slater JM. Dose response of rat retinal microvessels to proton dose schedules used clinically: A pilot study. Int J Radiat Oncol Biol Phys. 2000;48:1155-1166.
9. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, Swaroop A, Sowden JC. AliRR. Nature 2006;444:203-207.
10. LaVail MM, Anderson RE, Hollyfield JG. Inherited and Environment Induced Retinal Degeneration Series. New York: Alan R. Liss, 1989.
11. Moore RF. The value of radium in intraocular lesions. Trans Ophthalmol Soc UK 1935;55:2-26.
12. Amoaku WMK, Archer DB. Cephalic radiation and retinal vasculopathy. Eye 1990;4:195-203.
13. Merriam GR, Focht EF. The effects of ionizing radiation on the eye. Front Rad Ther Oncol. 1972;6:346-385.
14. Ehlers N. Kaaes: Effects of ionizing radiation retinoblastoma and on the normal ocular function in infants. A photographic and fluorescein angiographic study. Acta Ophthalmol. 1987;65:3-84.
15. Mao XW, Archambeau JO, Kubínová L, Boyle S, Petersen G, Grove R. Quantification of rat retinal growth and vascular population changes following single and split dose schedules of proton irradiation: Translational study using stereology methods. Rad Res. 2003;160:5-13.
16. Sun J, Chen Y, Li M, Ge Z. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Bio Med. 1998;24:586-593.
17. Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, Feng Q-F, Kang SK, Spasojevic I, Samulski TV, Fridovich I, Dewhirst MW, Anscher MS. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Rad Biol Med. 2002;33:857-863.
18. Lee JH, Park JW. A manganese porphyrin complex is a novel radiation protector. Free Radic Biol Med. 2004;37:272-283.
19. Lee JH, Lee YM, Park JW. Regulation of ionizing radiation-induced apoptosis by amanganese porphyrin complex. Biochem Biophys Res Commun. 2005;334:298-305.
20. Gauuan PJF, Trova MP, Gregor-Boros L, Bocckino SB, Crapo JD, Day BJ. Superoxide dismutase mimetics: Synthesis and structure3/4activity relationship study of MnTBAP analogues. Bioorgan Med Chem. 2002;10:3013-3021.
21. Day BJ, Fridovich I, Crapo JD. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys. 1997;347:256-262.
22. Day BJ, Batinic-Haberle I, Crapo JD. Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med. 1999;26:730-736.
23. Trova MP, Gauuan PJF, Pechulis AD, Bubb SM, Bocckino SB, Crapo JD, Day BJ. Superoxide dismutase mimetics. Part 2. Synthesis and structure3/4activity relationship of glyoxylate and glyoxamide-derived metalloporphyrins. Bioorg Med Chem. 2003;11:2695-2707.
24. Day BJ. Catalytic antioxidants: A radical approach to new therapeutics. Drug Discovery Today 2004;9:557-566.
25. Ellipse program. http://www.ellipse.sk.
26. Quintiliani M. The oxygen effect in radiation inactivation of DNA and enzymes. Int J Radiat Biol Relat Stud Phys Chem Med. 1986;50:573-594.
27. Day B. Catalytic antioxidants: A radical approach to new therapeutics. Drug Discovery Today 2004;13:557-566.
28. Mackensen GB, Patel M, Sheng H, Calvi CK, Batinić-Haberle I, Day BJ, Liang LP, Fridovich I, Crapo JD, Pearlstein RD, Warner DS. Neuroprotection from delayed post-ischemic administration of a metalloporphyrin catalytic antioxidant. J Neuro Sci. 2001;21:4582-4592.
29. Sheng H, Enghild JJ, Bowler R, Patel M, Batinic-Harberle I, Calvi CL, Day BJ, Pearlstein RD, Crapo JD, Warner DS. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic Biol Med. 2002;33:947-961.
30. Chang L, Crapo JD. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med. 2002;33:379-386.
31. Chang LY, Subramaniam M, Yoder BA, Day BJ, Ellison MC, Sunday ME, Crapo JD. A catalytic antioxidant prevents alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2003;167:57-64.
32. Lubbers NL, Polakowski J, Crapo JD, Wegner CD, Cox BR. Pre-ischemic and post-ischemic administration of AEOL 10113 reduces infarct size in a rat model of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 2003;41:714-719.
33. Gridley DS, Makinde AY, Luo X, Rizvi A, Crapo JD, Dewhirst MW, Moeller BJ, Pearlstein RD, Slater JM. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Res. 2007;27:3101-3109.
34. Shichi H. Cataract formation and prevention. Expert Opin Invest Drugs 2004;13(6):691-701.
35. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45(2):115-134.
36. Nakajima T. Positive and negative regulation of radiation-induced apoptosis by protein kinase C. J Radiat Res (Tokyo) 2008;49:1-8.
37. Rashi-Elkeles S, Elkon R, Weizman N, Linhart C, Shiloh Y. Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene. 2006;25:1584-1592.
38. Gobbel GT, Bellinzona M, Vogt AR, Gupta N, Fike JR, Chan PH. Response of postmitotic neurons to X-irradiation: Implications for the role of DNA damage in neuronal apoptosis. J Neurosci. 1998;18:147-155.
39. Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326(Pt 1):1-16.
40. Lyubimova N, Hopewell JW. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol. 2004;77:488-492.
41. Yu DY, Cringle SJ. Oxygen distribution and consumption within retina in vascularized and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:175-208.